세계의 의료용 바이오미메틱스 시장 규모 조사, 질환 유형별, 용도별, 지역별 예측(2022-2032년)

Global Medical Biomimetics Market is valued approximately USD 33.21 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.70% over the forecast period 2024-2032. Medical biomimetics combines biology, engineering, and materials science to develop novel approaches to medical problems. Researchers emulate biological processes, structures, and systems to create medical technologies that mimic nature's efficiency and adaptability. Medical biomimetics finds applications in prosthetics, tissue engineering, drug delivery, surgical tools, imaging, and beyond. This interdisciplinary approach promises to revolutionize healthcare by providing safer, more effective, and sustainable treatments and interventions. Moreover, AI is increasingly integrated into the design and development processes of biomimetic medical technologies. Machine learning algorithms are utilized to analyze complex biological systems, model biomimetic structures, optimize material properties, and accelerate the discovery of novel biomimetic solutions.

The increasing incidence of chronic diseases plays a significant role in supporting the growth of the Medical Biomimetics Market. Chronic diseases such as cardiovascular diseases, orthopedic disorders, diabetes, and neurological disorders present complex challenges in terms of treatment and management. Biomimetic materials and devices offer innovative solutions that can mimic natural biological structures and processes, providing more effective treatments for these conditions. Additionally, other factors support the market growth are increasing research and development activities, growing advancement in nanotechnology, rising demand for minimally invasive procedures, and increasing research and development investments. However, stringent regulatory framework, and high development costs are expected to hinder the market growth during the forecast period 2024-2032.

The key regions considered for the global Medical Biomimetics market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market. North America is projected to be the leading region in the Medical Biomimetics market, driven by factors such as an ageing population, rising prevalence of chronic illnesses, and ongoing advancements in biomimetic technology. As per NIH (National Institutes of Health), the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050. Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. As a result, the growing old age population and rising prevalence of chronic disease is anticipated to support the market growth.

Major market player included in this report are:

• Keystone Dental Group
• CorNeat Vision
• Syntouch Inc.
• Zimmer Biomet Holding Inc.
• Curasan, inc.
• Skyler Brand Ventures LLC
• Osteopore International Pte Ltd
• Blatchford Limited
• AVINENT Science and Technology
• Otsuka Medical Devices Co., Ltd.

The detailed segments and sub-segment of the market are explained below:

By Disease Type

• Ophthalmology
• Cardiovascular
• Orthopedic
• Dental
• Others

By Application

• Wound Healing
• Tissue Engineering
• Drug Delivery
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Medical Biomimetics Market Definition and Research Assumptions

• 1.1. Research Objective
• 1.2. Market Definition
• 1.3. Research Assumptions
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
  • 1.3.3. Supply Side Analysis
    • 1.3.3.1. Availability
    • 1.3.3.2. Infrastructure
    • 1.3.3.3. Regulatory Environment
    • 1.3.3.4. Market Competition
    • 1.3.3.5. Economic Viability (Consumer's Perspective)
  • 1.3.4. Demand Side Analysis
    • 1.3.4.1. Regulatory frameworks
    • 1.3.4.2. Technological Advancements
    • 1.3.4.3. Environmental Considerations
    • 1.3.4.4. Consumer Awareness & Acceptance
• 1.4. Estimation Methodology
• 1.5. Years Considered for the Study
• 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

• 2.1. Global Medical Biomimetics Market Size & Forecast (2022- 2032)
• 2.2. Regional Summary
• 2.3. Segmental Summary
  • 2.3.1. By Disease Type
  • 2.3.2. By Application
• 2.4. Key Trends
• 2.5. Recession Impact
• 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Medical Biomimetics Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Challenges
• 3.3. Market Opportunities

Chapter 4. Global Medical Biomimetics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Medical Biomimetics Market Size & Forecasts by Disease Type 2022-2032

• 5.1. Ophthalmology
• 5.2. Cardiovascular
• 5.3. Orthopedic
• 5.4. Dental
• 5.5. Others

Chapter 6. Global Medical Biomimetics Market Size & Forecasts by Application 2022-2032

• 6.1. Wound Healing
• 6.2. Tissue Engineering
• 6.3. Drug Delivery
• 6.4. Others

Chapter 7. Global Medical Biomimetics Market Size & Forecasts by Region 2022-2032

• 7.1. North America Medical Biomimetics Market
  • 7.1.1. U.S. Medical Biomimetics Market
    • 7.1.1.1. Disease Type breakdown size & forecasts, 2022-2032
    • 7.1.1.2. Application breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Medical Biomimetics Market
• 7.2. Europe Medical Biomimetics Market
  • 7.2.1. U.K. Medical Biomimetics Market
  • 7.2.2. Germany Medical Biomimetics Market
  • 7.2.3. France Medical Biomimetics Market
  • 7.2.4. Spain Medical Biomimetics Market
  • 7.2.5. Italy Medical Biomimetics Market
  • 7.2.6. Rest of Europe Medical Biomimetics Market
• 7.3. Asia-Pacific Medical Biomimetics Market
  • 7.3.1. China Medical Biomimetics Market
  • 7.3.2. India Medical Biomimetics Market
  • 7.3.3. Japan Medical Biomimetics Market
  • 7.3.4. Australia Medical Biomimetics Market
  • 7.3.5. South Korea Medical Biomimetics Market
  • 7.3.6. Rest of Asia Pacific Medical Biomimetics Market
• 7.4. Latin America Medical Biomimetics Market
  • 7.4.1. Brazil Medical Biomimetics Market
  • 7.4.2. Mexico Medical Biomimetics Market
  • 7.4.3. Rest of Latin America Medical Biomimetics Market
• 7.5. Middle East & Africa Medical Biomimetics Market
  • 7.5.1. Saudi Arabia Medical Biomimetics Market
  • 7.5.2. South Africa Medical Biomimetics Market
  • 7.5.3. Rest of Middle East & Africa Medical Biomimetics Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Keystone Dental Group
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. CorNeat Vision
  • 8.3.3. Syntouch Inc.
  • 8.3.4. Zimmer Biomet Holding Inc.
  • 8.3.5. Curasan, inc.
  • 8.3.6. Skyler Brand Ventures LLC
  • 8.3.7. Osteopore International Pte Ltd
  • 8.3.8. Blatchford Limited
  • 8.3.9. AVINENT Science and Technology
  • 8.3.10. Otsuka Medical Devices Co., Ltd.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes